Kynam Capital Management, LP
- SEC CIK
- 0001907884
- Latest filing
- Aug 14, 2026
CNTA holding history
Centessa Pharmaceuticals plc in every 13F filed by Kynam Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CNTA overviewAll 13F holders of CNTAFull Q2 2026 holdings
- Shares (Q1 2024)
- 0
- Sold out in Q1 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2024 | 0 | $0 | 0.0% | −442,704−100.0% | Sold out | Holders |
| Q4 2023 | 442,704 | $3.52M | 0.4% | −287,768−39.4% | Reduced | Holders |
| Q3 2023 | 730,472 | $4.73M | 0.8% | +1,395+0.2% | Added | Holders |
| Q2 2023 | 729,077 | $4.51M | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 729,077 | $2.81M | 0.4% | −4,849−0.7% | Reduced | Holders |
| Q4 2022 | 733,926 | $2.28M | 0.3% | +2,405+0.3% | Added | Holders |
| Q3 2022 | 731,521 | $2.94M | 0.6% | −26,327−3.5% | Reduced | Holders |
| Q2 2022 | 757,848 | $3.69M | 1.0% | +88,748+13.3% | Added | Holders |
| Q1 2022 | 669,100 | $6.00M | 2.0% | +430,059+179.9% | Added | Holders |
| Q4 2021 | 239,041 | $2.69M | 1.4% | – | No prior filing | Holders |